The long term risk of lead failure in patients with cardiovascular implantable electronic devices undergoing catheter ablation

被引:2
|
作者
Farkowski, Michal M. [1 ]
Maciag, Aleksander [1 ]
Ciszewski, Jan [1 ]
Kowalik, Ilona [1 ]
Syska, Pawel [1 ]
Sterlinski, Maciej [2 ]
Szwed, Hanna [1 ]
Pytkowski, Mariusz [1 ]
机构
[1] Inst Cardiol, Dept Coronary Artery Dis 2, Heart Arrhythmia Ward, Alpejska 42, PL-04628 Warsaw, Poland
[2] Inst Cardiol, Dept Heart Arrhythmia, Warsaw, Poland
关键词
Lead; damage; dysfunction; CIED; ablation; long-term; EXPERT CONSENSUS STATEMENT; RADIOFREQUENCY ABLATION; CARDIOVERTER-DEFIBRILLATOR; ATRIAL-FIBRILLATION; ESC GUIDELINES; COMPLICATIONS; MANAGEMENT; PACEMAKERS; EFFICACY; ARRHYTHMIAS;
D O I
10.1080/14017431.2019.1653489
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The aim of the study was to assess the long-term influence of catheter ablation (CA) of different arrhythmias on cardiovascular implantable electronic devices (CIED) endocardial leads durability. Design. This was a retrospective case-control study. Ablation protocols and in- or outpatient medical records were reviewed to identify and extract data on adult patients with CIED undergoing a CA. A cohort of patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators (ICD) served as a historical control group. The primary endpoint was the diagnosis of lead damage defined as permanent loss of proper function demanding replacement or removal. Results. Among 145 patients n = 177 catheter ablations were performed. Patients' mean age was 66.4 +/- 10.5, 66.1% had an ICD or ICD with cardiac resynchronization function (CRT-D), 18.1% had >1 CA. During median 812 days [IQR 381-1588] of follow-up, there were 11 (6.2%) cases of lead damage in the examined and 13 cases (13%) in the control group, p = 0.054. None of the technical aspects of the CA (indication, type of catheter, transseptal sheath) influenced the primary outcome. Both the number of leads and observation time after CA were significantly related to the risk of endocardial lead damage. Conclusion. This study did not find any significant influence of CA on the long-term durability of CIED endocardial leads. Reported risk factors were consistent with general population of CIED patients.
引用
收藏
页码:323 / 328
页数:6
相关论文
共 50 条
  • [31] Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia
    Kamada, Hiroyuki
    Kaneyama, Junji
    Inoue, Yuko Y.
    Noda, Takashi
    Ueda, Nobuhiko
    Nakajima, Kenzaburo
    Kamakura, Tsukasa
    Wada, Mitsuru
    Ishibashi, Kohei
    Yamagata, Kenichiro
    Miyamoto, Koji
    Aoki, Tatsuo
    Ogo, Takeshi
    Nagase, Satoshi
    Aiba, Takeshi
    Satomi, Kazuhiro
    Kusano, Kengo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Magnetic Field Measurements of Portable Electronic Devices: The Risk Inside Pockets for Patients With Cardiovascular Implantable Devices
    Fery, Corentin
    Desombre, Adrien
    Quirin, Thomas
    Badertscher, Patrick
    Sticherling, Christian
    Knecht, Sven
    Pascal, Joris
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2022, 15 (03):
  • [33] Economic Considerations of Cardiovascular Implantable Electronic Devices for The Treatment of Heart Failure
    Elsner, Christian
    Bettin, Simon
    Tilz, Roland
    Haeckl, Dennis
    CURRENT HEART FAILURE REPORTS, 2024, 21 (03) : 186 - 193
  • [34] Increased Long-Term Mortality in Patients with Cardiovascular Implantable Electronic Device Infections
    Sohail, Muhammad Rizwan
    Henrikson, Charles A.
    Braid-Forbes, Mary Jo
    Forbes, Kevin F.
    Lerner, Daniel J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02): : 231 - 239
  • [35] Management of bacteremia in patients living with cardiovascular implantable electronic devices
    DeSimone, Daniel C.
    Sohail, M. Rizwan
    HEART RHYTHM, 2016, 13 (11) : 2247 - 2252
  • [36] Cryoballoon ablation of atrial fibrillation in patients with advanced systolic heart failure and cardiac implantable electronic devices
    Pruszkowska, Patrycja
    Lenarczyk, Radoslaw
    Gumprecht, Jakub
    Jedrzejczyk-Patej, Ewa
    Mazurek, Michal
    Kowalski, Oskar
    Sokal, Adam
    Podolecki, Tomasz
    Morawski, Stanislaw
    Streb, Witold
    Mitrega, Katarzyna
    Kalarus, Zbigniew
    KARDIOLOGIA POLSKA, 2018, 76 (07) : 1081 - 1088
  • [37] Cardiovascular implantable electronic devices in hemodialysis patients: an updated review
    Spatola, Leonardo
    Rivera, Rodolfo F.
    Migliore, Federico
    Bilato, Claudio
    Mugnai, Giacomo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (12) : 867 - 873
  • [38] Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure
    Samuel, Michelle
    Abrahamowicz, Michal
    Joza, Jacqueline
    Beauchamp, Marie-Eve
    Essebag, Vidal
    Pilote, Louise
    EUROPACE, 2020, 22 (05): : 739 - 747
  • [39] Risk Profiles and Outcomes of Patients Receiving Cardiovascular Implantable Electronic Devices With and Without Antibacterial Envelopes
    Woodard, David A.
    Kim, Grace
    Nilsson, Kent R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [40] Zero-fluoroscopy ablation in patients with cardiac electronic implantable devices
    Shimamoto, Keiko
    Yamagata, Kenichiro
    Wakamiya, Akinori
    Ueda, Nobuhiko
    Kamakura, Tsukasa
    Wada, Mitsuru
    Inoue-Yamada, Yuko
    Miyamoto, Koji
    Nagase, Satoshi
    Kusano, Kengo F.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2022, 33 (03) : 423 - 429